One-Page Truth-Telling Aid for Cancer Disclosure

Summary

The goal of this clinical trial is to learn whether a one-page communication aid can improve communication between physicians and patients with cancer during cancer-related truth-telling consultations. The one-page aid is designed to help physicians quickly understand patients' preferences and needs before the consultation. The main questions it aims to answer are: * Does the one-page communication aid improve patients' satisfaction with how cancer-related information is explained? * Does the one-page communication aid reduce patients' emotional distress after the consultation? * Does the one-page communication aid improve physicians' confidence in communicating cancer-related information? Researchers will compare patients whose physicians receive the one-page communication aid with patients whose physicians provide usual care with a blank sheet for patients to write down questions. This comparison will help determine whether the one-page aid improves communication, emotional outcomes, and physician confidence. Participants will: * Complete questionnaires before and after the consultation * Receive either the one-page communication aid or a blank sheet, depending on their physician's group * Complete follow-up questionnaires at 3 months and 6 months after the consultation Physicians will also complete brief questionnaires about their communication confidence at baseline, 1 week after recruitment of their first enrolled patient, 3 months, and 6 months.

Eligibility

【Physicians】

* Inclusion Criteria:

  * Physicians who provide clinical care for patients with cancer in participating outpatient departments.
  * Physicians who are involved in cancer-related truth-telling or disclosure consultations.
  * Physicians who are willing to participate and provide informed consent.
* Exclusion Criteria:

  * Physicians who are unable or unwilling to complete study procedures or follow-up assessments.

【Patients】

* Inclusion Criteria:

  * Patients diagnosed with cancer.
  * Patients who are scheduled to receive cancer-related information from a participating physician, including information about diagnosis, recurrence, metastasis, end-of-life status.
  * Patients who are able to communicate in Mandarin Chinese or Taiwanese.
  * Patients who are able to complete questionnaires independently or with assistance from the research assistant.
  * Patients who are willing to participate and provide informed consent.
* Exclusion Criteria:

  * Patients who are unable to provide informed consent.
  * Patients with severe cognitive impairment, severe physical illness, or emotional distress that prevents participation, as judged by the clinical team or research staff.
  * Patients who are unable to complete the study questionnaires even with assistance.

Conditions7

Browse More Trials